Core Viewpoint - Weigao Group has signed a non-binding letter of intent for a potential acquisition of 100% equity in Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd by Weigao Blood Purification Products Co., Ltd, indicating strategic expansion in the pharmaceutical packaging sector [1][2] Group 1: Company Overview - Weigao Blood Purification Products Co., Ltd is primarily engaged in the research, production, and sales of medical products for blood purification, including hemodialyzers, blood dialysis tubing, dialysis machines, and peritoneal dialysis solutions [1] - As of the announcement date, Weigao Blood Purification is controlled by Weigao Group, which holds a 23.53% direct stake in the company [1] Group 2: Weigao Purui Overview - Weigao Purui focuses on the research, production, and sales of pre-filled drug delivery systems and automatic safety drug delivery systems, aiming to provide comprehensive drug delivery solutions for global biopharmaceutical companies [2] - Weigao Purui is a non-wholly owned subsidiary of the company, with ownership stakes of 94.0706% by the company, 4.0215% by Weihai Shengxi, and 1.9078% by Weihai Ruiming [2]
威高股份威高普瑞拟出售山东威高普瑞医药包装100%的股权